Eisai: DIAN-TU Selects Lecanemab as Background Anti-Amyloid Therapy in Clinical Trial Evaluating Investigational Therapy Targeting Tau for Dominantly Inherited Alzheimer’s Disease
TOKYO, Nov 9, 2021 – (JCN Newswire) – Eisai Co., Ltd. announced today that the…
Dynamic Expands to Loudoun County, Virginia — Meeting Customer Demand for Secure, Sustainable ITAD and Data Center Services in “Data Center Alley”
Prompt Infrastructure as the New Battleground for AI Assistants
Building Real Software Supply Chain Resilience in a Time of Rising Pressure